201 related articles for article (PubMed ID: 12857370)
1. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
Meyer-Wentrup F; Burdach S
J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
[TBL] [Abstract][Full Text] [Related]
2. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
3. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection.
Felzmann T; Witt V; Wimmer D; Ressmann G; Wagner D; Paul P; Hüttner K; Fritsch G
Cytotherapy; 2003; 5(5):391-8. PubMed ID: 14578101
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional comparison between flask adherent and magnetic activated cell sorted monocytes derived dendritic cells.
Delirezh N; Shojaeefar E
Iran J Immunol; 2012 Jun; 9(2):98-108. PubMed ID: 22735797
[TBL] [Abstract][Full Text] [Related]
5. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Curti A; Isidori A; Ferri E; Terragna C; Neyroz P; Cellini C; Ratta M; Baccarani M; Lemoli RM
Leuk Lymphoma; 2004 Jul; 45(7):1419-28. PubMed ID: 15359643
[TBL] [Abstract][Full Text] [Related]
6. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation.
Wang YS; Chi KH; Liao KW; Liu CC; Cheng CL; Lin YC; Cheng CH; Chu RM
Can J Vet Res; 2007 Jul; 71(3):165-74. PubMed ID: 17695590
[TBL] [Abstract][Full Text] [Related]
7. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
[TBL] [Abstract][Full Text] [Related]
8. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC.
Suen Y; Lee SM; Aono F; Hou S; Loudovaris M; Ofstein G; Bender JG
Cytotherapy; 2001; 3(5):365-75. PubMed ID: 11953016
[TBL] [Abstract][Full Text] [Related]
9. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device.
Perseghin P; D'Amico G; Dander E; Gaipa G; Dassi M; Biagi E; Biondi A
Transfusion; 2008 Aug; 48(8):1644-9. PubMed ID: 18513258
[TBL] [Abstract][Full Text] [Related]
10. Monocyte enrichment from leukapheresis products by using the Elutra cell separator.
Kim S; Kim HO; Baek EJ; Choi Y; Kim HS; Lee MG
Transfusion; 2007 Dec; 47(12):2290-6. PubMed ID: 17764512
[TBL] [Abstract][Full Text] [Related]
11. A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.
Balan S; Kale VP; Limaye LS
Transfusion; 2009 Oct; 49(10):2109-21. PubMed ID: 19497054
[TBL] [Abstract][Full Text] [Related]
12. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
Uslu U; Erdmann M; Wiesinger M; Schuler G; Schuler-Thurner B
Cytotherapy; 2019 Nov; 21(11):1166-1178. PubMed ID: 31668486
[TBL] [Abstract][Full Text] [Related]
13. Clinical-scale generation of dendritic cells in a closed system.
Sorg RV; Ozcan Z; Brefort T; Fischer J; Ackermann R; Müller M; Wernet P
J Immunother; 2003; 26(4):374-83. PubMed ID: 12843800
[TBL] [Abstract][Full Text] [Related]
14. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
Pullarkat V; Lau R; Lee SM; Bender JG; Weber JS
J Immunol Methods; 2002 Sep; 267(2):173-83. PubMed ID: 12165439
[TBL] [Abstract][Full Text] [Related]
15. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
[TBL] [Abstract][Full Text] [Related]
17. Accessory cells with a veiled morphology and movement pattern generated from monocytes after avoidance of plastic adherence and of NADPH oxidase activation. A comparison with GM-CSF/IL-4-induced monocyte-derived dendritic cells.
Ruwhof C; Canning MO; Grotenhuis K; de Wit HJ; Florencia ZZ; de Haan-Meulman M; Drexhage HA
Immunobiology; 2002 Jul; 205(3):247-66. PubMed ID: 12182452
[TBL] [Abstract][Full Text] [Related]
18. Efficiency and Impact of Positive and Negative Magnetic Separation on Monocyte Derived Dendritic Cell Generation.
Kowalewicz-Kulbat M; Ograczyk E; Włodarczyk M; Krawczyk K; Fol M
Iran J Immunol; 2016 Jun; 13(2):132-40. PubMed ID: 27350634
[TBL] [Abstract][Full Text] [Related]
19. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration.
Videira PA; Silva M; Martin KC; Sackstein R
J Immunol; 2018 Aug; 201(3):1030-1043. PubMed ID: 29941663
[TBL] [Abstract][Full Text] [Related]
20. Development of a technology platform for large-scale clinical grade production of DC.
Adamson L; Palmborg A; Svensson A; Lundqvist A; Hansson M; Kiessling R; Masucci G; Mellstedt H; Pisa P
Cytotherapy; 2004; 6(4):363-71. PubMed ID: 16146889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
